| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |